Nandi Deipanjan, Rossano Joseph W
Cardiac Center,The Children's Hospital of Philadelphia,Perelman School of Medicine at the University of Pennsylvania,Philadelphia,Pennsylvania,United States of America.
Cardiol Young. 2015 Dec;25(8):1460-8. doi: 10.1017/S1047951115002280.
Heart failure in children is a complex disease process, which can occur secondary to a variety of aetiologies, including CHD, cardiomyopathy, or acquired conditions as well. Although the overall incidence of disease is low, the associated morbidity and mortality are high. Mortality may have decreased slightly over the last decade, and this is likely due to our ability to shepherd patients through longer periods of significant morbidity, with lasting effects. Costs of heart failure are significant - on the order of $1 billion annually as hospital charges for inpatient admissions alone. The value, or benefit to patient life and quality of life at this cost, is not well delineated. Further research is needed to optimise not only outcomes for these patients but also the high costs associated with them.
儿童心力衰竭是一个复杂的疾病过程，可继发于多种病因，包括先天性心脏病（CHD）、心肌病或后天性疾病。尽管该疾病的总体发病率较低，但其相关的发病率和死亡率却很高。在过去十年中，死亡率可能略有下降，这可能是由于我们有能力让患者在较长时间内承受严重的发病率，并产生持久影响。心力衰竭的成本很高——仅住院患者的住院费用每年就达10亿美元左右。以这种成本对患者生命和生活质量的价值或益处尚未明确界定。需要进一步研究，不仅要优化这些患者的治疗结果，还要优化与之相关的高昂成本。
